Interviews Archives - Page 5 of 7

Elliot Lander & Mark Berman Interview Part 1: A Window into Cell Surgical Network

November 22, 2013 / Professor Paul Knoepfler, Ph.D. / 9 Comments

The Cell Surgical Network is a large and growing group of affiliated stem cell clinics across the US. The Network providers use stromal vascular fraction (SVF) interventions for a host of conditions on a for-profit basis. Drs. Elliot Lander and Mark Berman lead the Network. They agreed to do a Q&A interview with me. Below is Part 1, […]

Elliot Lander & Mark Berman Interview Part 1: A Window into Cell Surgical Network Read More »

Interview With Organizers of Tomorrow’s Berkeley Stem Cell Meeting

October 11, 2013 / Professor Paul Knoepfler, Ph.D. / 1 Comment

I’m really looking forward to this Saturday’s Berkeley Stem Cell Meeting. You should go! Tickets are just $5 and the lineup is great. This looks to be one of the best stem cell meetings in Northern California this year. Below is my interview with the organizers giving some background and perspectives on the meeting. 1.

Interview With Organizers of Tomorrow’s Berkeley Stem Cell Meeting Read More »

Interview with Roman Reed on Guv Grown’s Veto of AB714 Spinal Cord Injury Research Bill

October 7, 2013 / Professor Paul Knoepfler, Ph.D. / 2 Comments

Unfortunately California Guv Jerry Brown vetoed AB714, the Roman Reed Act that would have greatly supported spinal cord research. Roman Reed is of course a top stem cell patient advocate and driving force in research. Roman received my Stem Cell Person of the Year Award last year (See picture at right). The contest for the

Interview with Roman Reed on Guv Grown’s Veto of AB714 Spinal Cord Injury Research Bill Read More »

Joanne Kurtzberg interview, Part 2: clinics & stem cell field future

August 15, 2013 / Professor Paul Knoepfler, Ph.D. / 7 Comments

I recently conducted an interview with Dr. Joanne Kurtzberg of Duke. You can see Part 1 of the interview here. Today in Part 2, I asked Dr. Kurtzberg some broader questions about the stem cell field. 1. How concerned are you about non-compliant stem cell interventions here in the US as well as stem cell

Joanne Kurtzberg interview, Part 2: clinics & stem cell field future Read More »

Stem Cell Pioneer Joanne Kurtzberg interview, Part 1

August 6, 2013 / Professor Paul Knoepfler, Ph.D. / 8 Comments

Dr. Joanne Kurtzberg is a stem cell pioneer and has advanced the development of innovative stem cell therapies including those based on umbilical cord blood. She is a faculty member at Duke where she conducts her clinical research. I recently interviewed Dr. Kurtzberg and below is Part 1 of 2 of the interview. Part 2,

Stem Cell Pioneer Joanne Kurtzberg interview, Part 1 Read More »

Mike West Interview Part 3: key flaw in stem cell field

July 11, 2013 / Professor Paul Knoepfler, Ph.D. / 7 Comments

Michael-West-PhD-CEO-of-BioTime-1-934x10241

I’m doing a series of posts on my recent conversation with BioTime CEO and pioneer of the stem cell field, Dr. Mike West. You can read Part 1 and Part 2 on Geron, ACT, and the history of the pluripotent stem cell field, particularly embryonic stem cells (ESCs). Today in Part 3, I am focusing on

Mike West Interview Part 3: key flaw in stem cell field Read More »

Janet Rossant, ISSCR President, on her goals, cloning, non-compliant clinics, iPS cells, and future of field

July 8, 2013 / Professor Paul Knoepfler, Ph.D. / 1 Comment

New ISSCR President, Dr. Janet Rossant, kindly agreed to do an interview with me focused on the future of ISSCR, her plans for her tenure, and some key issues in the field. Dr. Rossant is Chief of Research at The Hospital for Sick Children in Toronto. 1. The stem cell arena is a very rapidly changing one

Janet Rossant, ISSCR President, on her goals, cloning, non-compliant clinics, iPS cells, and future of field Read More »

BioTime CEO Mike West Interview Part 2: Geron & hESC

July 1, 2013 / Professor Paul Knoepfler, Ph.D. / 3 Comments

When you want to both know the real history of the pluripotent stem cell-based biotech industry and perspectives on its future, there are only a handful of people to turn to and one of them is definitely Dr. Michael West, CEO of BioTime. I’m doing a several part series of blog posts on a lengthy

BioTime CEO Mike West Interview Part 2: Geron & hESC Read More »

Interview with BioTime CEO Michael West Part 1: a little stem cell history

June 26, 2013 / Professor Paul Knoepfler, Ph.D. / 6 Comments

It was my pleasure recently to talk at length with Dr. Michael West, CEO of the Stem Cell Biotech, BioTime (BTX). West has been at the helm of BioTime since 2007 and is a true pioneer in the stem cell field. He founded Geron (GERN) and was a top leader at Advanced Cell Technology (ACT; stock

Interview with BioTime CEO Michael West Part 1: a little stem cell history Read More »

Stemage Stem Cell Anti-Aging Cream 2.0: Interview with Dr. David Scharp

June 11, 2013 / Professor Paul Knoepfler, Ph.D. / 5 Comments

Remember Stemage? They are the cosmetic company with Kathy Ireland as their spokesperson whose anti-aging cream includes extracts from human stem cells. In Part 1 of this blog series on Stemage I gave some key background and raised some important questions. I also sent some questions to the company and now more recently to the

Stemage Stem Cell Anti-Aging Cream 2.0: Interview with Dr. David Scharp Read More »

Interviews

Subscribe to Our Newsletter